Target intelligence / Profile preview

M2-2 protein of human respiratory syncytial virus (M2-2)

Target
M2-2
Molecular classification
Other (viral regulatory protein)
01

Overview

The M2-2 protein is a small regulatory protein encoded by the human respiratory syncytial virus (RSV). It plays a crucial role in the viral life cycle, acting as a molecular switch to downregulate viral mRNA transcription and promote synthesis of genomic and antigenomic RNA required for virion assembly[2][3][7]. M2-2 also interacts with host proteins, influencing cellular translation and potentially localizing to nuclear sites involved in mRNA splicing[1]. The protein is not an endogenous human molecule or therapeutic target but is instead a viral factor that regulates RSV replication and infection dynamics[2][7]. Note: While M2-2 could be investigated for virus biology or vaccine research, it is not considered a direct therapeutic target, biomarker, or druggable receptor/enzyme/transporter in any known clinical setting[7]. If your question refers to a human regulatory protein, this entry may be based on a mistaken name or context.

Other names
Protein M2-2RSV M2-2
02

Mechanism of action

Not applicable (not a therapeutic target for existing drugs)

03

Biological functions

Negative regulation of viral mRNA transcriptionInduction of the switch from viral mRNA transcription to viral RNA genome replicationModulation of host cell translation and stress pathways
04

Disease associations

Infection (specifically respiratory syncytial virus infection)
05

Safety considerations

Not applicable (not used therapeutically)
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on M2-2 protein of human respiratory syncytial virus (M2-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on M2-2 protein of human respiratory syncytial virus (M2-2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call